Product Information
GLYBURIDE 2.5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0759 per EA under NDC 75834020301. Its NADAC has been published 282 times since Oct 16, 2019.
FDA first approved this application on Jan 4, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834020301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203379FDA Approved
1/4/2019
TE Code
AB1
On Market Since
1/25/2019
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 2.5 MG TABLET has been published 282 times since Oct 16, 2019, and over the history we have for it it has declined 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0759 per EA |
|---|---|
| All-time high | $0.1048 (Nov 10, 2021) |
| All-time low | $0.0548 (May 22, 2024) |
| Median price | $0.0838 |
| Average price | $0.0849 |
| Largest weekly change | +67.8% (Jun 19, 2024) |
| Weeks tracked | 282 |
| Tracking since | Oct 16, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-5.7%
5Y
-23.8%
All
-18.1%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 2.5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0759 per EA (NDC 75834020301), effective Mar 5, 2025.
How has the price of GLYBURIDE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 2.5 MG TABLET has declined 18.1%. It has been tracked across 282 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 2.5 MG TABLET?
Since Oct 16, 2019, the NADAC for GLYBURIDE 2.5 MG TABLET has ranged from a low of $0.0548 (May 22, 2024) to a high of $0.1048 (Nov 10, 2021), with a median of $0.0838 per EA.
Are there cheaper alternatives to GLYBURIDE 2.5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE 2.5 MG TABLET, is $0.0668 per EA — about 12% below GLYBURIDE 2.5 MG TABLET.
Who manufactures GLYBURIDE 2.5 MG TABLET?
GLYBURIDE 2.5 MG TABLET (NDC 75834020301) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.